Cyclooxygenase-2 (COX-2), which converts arachidonic acid into thromboxanes and prostaglandins, has been reported to be a key molecule mediating TME changes and contributes to immune evasion as well as resistance to cancer immunotherapy [456,457]. This evidence concerns the gene PTGS2 and cancer.